Stocktoria

SS Innovations International, Inc. SSII

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2018-07-09 · LEI

SS Innovations International, Inc. financials (annual)

Revenue
$5.9M $20.6M $42.5M 2016201720182019202020212022202320242025
Net income
-$484982 -$1.0M -$960322 -$3.4M -$1.1M -$1.5M -$5.6M -$20.9M -$19.2M -$12.1M 2016201720182019202020212022202320242025
Free cash flow
-$5.8M -$15.8M -$10.2M -$22.2M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$42.5M$20.6M$5.9M
Gross profit$19.5M$8.5M$725,528$489,594
R&D expense$3.7M$2.5M$1.1M$83,282$1,000$3,000$60,874$27,125$71,170$127,578
SG&A expense$14.8M$10.2M$10.1M$3.3M
Operating income-$8.2M-$19.0M-$20.3M-$5.7M
Interest expense$523,356$161,999$1,059$19,748$27,000$22,520
Income tax$4.0M
Net income-$12.1M-$19.2M-$20.9M-$5.6M-$1.5M-$1.1M-$3.4M-$960,322-$1.0M-$484,982
EPS (diluted)$-0.06$-0.11$-0.14$-0.14$-0.05$-0.05$-0.16
Operating cash flow-$18.5M-$9.5M-$15.4M-$5.6M-$363,034-$90,540-$424,105-$443,288-$446,856-$211,944
Free cash flow-$22.2M-$10.2M-$15.8M-$5.8M
Cash & equivalents$3.2M$466,500$2.0M$1.5M$405,774$160,709$28,474$35,716$452,572$248,219
Inventory$17.1M$10.2M$7.0M$855,777
Total assets$74.2M$42.4M$31.5M$8.7M$428,607$317,870$132,524$145,434$509,962$292,232
Total liabilities$36.0M$28.9M$11.8M$11.1M$1.2M
Shareholders' equity$38.2M$13.5M$19.7M-$2.7M-$166,380-$869,049-$1.1M-$223,037$101,093-$355,060

Growth · year-over-year · Revenue CAGR 168.9%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+105.7%+251.5%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.